Trans-Pacific Partnership (TPP) Implementation and other proposed changes
Following extensive public consultation, PHARMAC has decided to make some changes to its Operating Policies and Procedures (OPP).
General OPP changes come into effect immediately and other changes that meet New Zealand’s obligations under the Trans-Pacific Partnership (TPP) will take effect once the TPP does.
This was subject of a consultation dated September 2016.
These administrative changes would further enhance PHARMAC’s thorough processes and don’t change the heart of the PHARMAC model.
PHARMAC will still get the best health gains by seeking expert clinical advice, undertaking rigorous value for money assessments, carefully applying the factors for consideration and taking part in the usual round of robust commercial processes.
From Whangarei to Invercargill, we were really pleased with the engaged conversation at all the forums and meetings nationwide.
We’re making some administrative changes now, based on the feedback we received, but the TPP-related changes would only come into effect when TPP does for New Zealand.
- A summary of the main themes arising from consultation and all the changes PHARMAC is making are detailed in the notification letter.
- Other changes to come into effect once the TPP does for New Zealand include:
- A new decision-type ‘decline as proposed’
- An online application process and Product Application Assessment Record (PAAR)
Public feedback has always been an important part of PHARMAC’s decision-making process and we’d like to thank everyone who attended one the forums or submitted their feedback online.
Your feedback has been very valuable to PHARMAC and the development of these changes.
The full details of the changes have been published on the PHARMAC website.
We received a lot of high quality feedback from the public throughout our consultation. A summary of the feedback can also be found on the PHARMAC website.
Last updated: 21 March 2017